Related Experiment Videos
[Obstruction of TGF-beta1 signal transduction can decrease the process of hepatocellular carcinoma in mice induced by
Xin-Bao Xu1, Xi-Sheng Leng, Xiao Yang
1Hepatobiliary Surgery Department, People's Hospital, Beijing University, Beijing 100044, China.
Zhonghua Yi Xue Za Zhi
|August 18, 2004
Summary
Antisense Smad4 gene transfer inhibited liver fibrosis and reduced liver cancer size and number in mice by blocking TGF-beta1 signaling. This approach shows potential for treating liver disease progression.
Area of Science:
- Molecular biology
- Hepatology
- Oncology
Context:
- Liver fibrosis and cancer are significant health concerns.
- Transforming growth factor-beta1 (TGF-beta1) signaling plays a role in liver disease.
- Smad4 is a key mediator in the TGF-beta1 pathway.
Purpose:
- To investigate the effect of antisense Smad4 on TGF-beta1 signal transduction.
- To evaluate the impact of Smad4 gene obstruction on experimental liver fibrosis and cancer in mice.
Summary:
- Antisense Smad4 cDNA was delivered to a mouse model of liver cancer.
- Successful gene transfer and downregulation of Smad4 expression were confirmed.
- Treatment reduced liver fibrosis and inhibited liver cancer progression, decreasing tumor size and number.
Impact:
- Antisense Smad4 gene therapy can obstruct TGF-beta1 signaling.
- This approach shows potential for treating liver fibrosis and inhibiting liver cancer progression.